Source: Journal of Nuclear Cardiology. Unidades: FMRP, FM, EESC, IMT
Subjects: MICROCIRCULAÇÃO, HAMSTERS, DOENÇAS CARDIOVASCULARES, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANAKA, Denise Mayumi et al. Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy. Journal of Nuclear Cardiology, v. 26, n. 5, p. 1569-1579, 2019Tradução . . Disponível em: https://doi.org/10.1007/s12350-018-1198-7. Acesso em: 26 ago. 2024.APA
Tanaka, D. M., Oliveira, L. F. L. de, Marin Neto, J. A., Romano, M. M. D., Carvalho, E. E. V. de, Barros Filho, A. C. L. de, et al. (2019). Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy. Journal of Nuclear Cardiology, 26( 5), 1569-1579. doi:10.1007/s12350-018-1198-7NLM
Tanaka DM, Oliveira LFL de, Marin Neto JA, Romano MMD, Carvalho EEV de, Barros Filho ACL de, Ribeiro FFF, Cabeza JM, Lopes CD, Fabricio CG, Kesper N, Moreira HT, Wichert-Ana L, Schmidt A, Higuchi M de L, Cunha-Neto E, Simões MV. Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy [Internet]. Journal of Nuclear Cardiology. 2019 ; 26( 5): 1569-1579.[citado 2024 ago. 26 ] Available from: https://doi.org/10.1007/s12350-018-1198-7Vancouver
Tanaka DM, Oliveira LFL de, Marin Neto JA, Romano MMD, Carvalho EEV de, Barros Filho ACL de, Ribeiro FFF, Cabeza JM, Lopes CD, Fabricio CG, Kesper N, Moreira HT, Wichert-Ana L, Schmidt A, Higuchi M de L, Cunha-Neto E, Simões MV. Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy [Internet]. Journal of Nuclear Cardiology. 2019 ; 26( 5): 1569-1579.[citado 2024 ago. 26 ] Available from: https://doi.org/10.1007/s12350-018-1198-7